Abstract
Objective: To assess the perception of pharmacovigilance by healthcare professionals practicing at the University Teaching Hospital of Cocody (Ivory Coast) in 2017. Methodology: A descriptive and analytic cross-sectional survey has been conducted in 2017 at the University Teaching Hospital of Cocody. This survey involved a sample of healthcare professionals practicing in 17 services who are prescribing medications and gave their oral consent. Results: A response rate of 54.08% (106/196) among physicians versus 43.87% (86/196) for the nurses and 27.61% (21/76) for the mid-wives. 57.94% (62/107) of paramedics versus 94.33% (100/106) of physicians had already heard about pharmacovigilance, during their basic training (40.18% of paramedics versus 73.58% of doctors). However, the main obstacles to the practice of pharmacovigilance were it teaching hours considered insufficient (94.39% of paramedics versus 75.47% of physicians), the lack of knowledge on the location of the pharmacovigilance unit (80.37% of paramedics versus, 40% of physicians) and the reporting of the adverse drug reactions to a hierarchical supervisor (60.60% of paramedics versus 37.25% of physicians). A regular visit of pharmacovigilance monitors in the hospital services (34.57% of paramedics versus 29.24% of physicians) and the availability of reporting forms (30.84% of paramedics versus 27.35% of physicians) could improve the perception of pharmacovigilance by the healthcare professionals. Conclusion: Our investigational survey has highlighted some factors that may influence the perception of pharmacovigilance by the healthcare professionals in Ivory Coast.
Highlights
Pharmacovigilance is an essential element of drug safety
The drawback has been the reporting of a small number of adverse drug reactions (ADRs) and the lack of reassessment of the benefit-risk ratio of the drugs commercialized in Ivory Coast
In Ivory Coast, few studies have shown that ADRs are poorly reported by healthcare professionals [5] and our study is the first to focus on the perception of pharmacovigilance at Cocody University Hospital Center (CHU)
Summary
Pharmacovigilance is an essential element of drug safety. it is a wellestablished activity in developed countries, it remains non-functional in Ivory Coast despite the existence of regulatory Acts organizing the National Pharmacovigilance System [1] [2] [3] [4]. The drawback has been the reporting of a small number of adverse drug reactions (ADRs) and the lack of reassessment of the benefit-risk ratio of the drugs commercialized in Ivory Coast In this context, the Clinical Pharmacology Department of the University Teaching Hospital (CHU) of Cocody-Abidjan has implemented a local pharmacovigilance system which collects, evaluates and prevents ADRs at the CHU of Cocody. The Clinical Pharmacology Department of the University Teaching Hospital (CHU) of Cocody-Abidjan has implemented a local pharmacovigilance system which collects, evaluates and prevents ADRs at the CHU of Cocody To be effective, this pharmacovigilance system requires the voluntary declaration of adverse drug reaction (ADR), especially those that are serious and/or unexpected in hospital. These healthcare professionals were targeted on the basis that: on one hand, they represented in 2017 the majority of healthcare personnel at the CHU of Cocody; on the other hand, because of their key role in prescribing, administering and monitoring the drugs
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
